· Vision and Mission
Qizheng Tibetan Medicine has been awarded the “Best New Media Operations Award for Investor Relations of Chinese Listed Companies.”
Release time:
2022-04-22 15:42
On April 22, the list of winners for the 13th China Listed Companies Investor Relations Tianma Awards was announced. Qizheng Tibetan Medicine was awarded the “Best New Media Operations Award for Investor Relations among Chinese Listed Companies,” making it the only company from the Southwest region to receive this prestigious honor.
It is reported that this selection was organized by the Securities Times, and after undergoing multiple rounds of screening and rigorous review by the Shanghai and Shenzhen Stock Exchanges, a group of companies were chosen for their outstanding management capabilities, which have earned them widespread recognition from both the market and investors. The Tianma Awards are among the earliest evaluation initiatives in China’s mainstream media to focus specifically on investor relations management in the capital markets. During this year’s Tianma Awards selection process, more than 1,000 listed companies actively nominated themselves, and nearly 6 million votes were cast, making it an event with tremendous influence.
The new media operations for investor relations at Qizheng Tibetan Medicine are part of the company’s digital transformation.
In 2021, following preliminary research and preparation, the official launch of the “Qizheng Tibetan Medicine Investor Relations Platform” WeChat public account and the “Qizheng Tibetan Medicine Investor Relations” mini-program—serving both the company’s existing investors and potential investors—was announced.
The “Qizheng Tibetan Medicine Investor Relations Platform” WeChat official account is a channel through which the company, in addition to its statutory information disclosures, conveys to investors its corporate vision and values, updates on R&D, production, and operations, financial performance, corporate social responsibility and charitable initiatives, and accolades. It also serves as a platform where investors can access enterprise news and insights anytime, anywhere, and ask questions or seek clarification from the company. Since its launch, this official account has demonstrated excellent interactivity with its subscribers. As exemplified by the activity at the end of the article “Flowers Falling at Qizheng—The Only National Technology Innovation Demonstration Enterprise for Ethnic Medicines,” over 150 people participated in the activity and claimed their prizes.
The “Qizheng Tibetan Medicine Investor Relations” mini-program is one of the platforms the company uses to host online investor events. In 2021, the company leveraged the “Qizheng Tibetan Medicine Investor Relations” mini-program to hold an online briefing on its first-half 2021 financial results. The event attracted over 70 investors and investment institutions, and the professionalism of their questions received high praise from the company’s president.
Ms. Feng Ping, Vice President and Board Secretary of Qizheng Tibetan Medicine, stated: “Investors are key stakeholders for Qizheng Tibetan Medicine. The interactivity, social nature, and immediacy of new media can effectively meet investors’ needs and demands for understanding the company, while also providing the company with an additional, convenient channel to communicate with investors—within the bounds of legality and compliance—and to address their questions and concerns.”
In this selection, Qizheng Tibetan Medicine also won the “Best Board Secretary Award for Investor Relations among Mainboard Listed Companies.”
Copyright Qizheng Tibetan Medicine Co., Ltd. All rights reserved. ICP Filing Number:
Internet drug information service qualification certificate number:（藏） Non-Commercial - 2018-0004 SEO